[4-prenyl-1,2-diphenyl-3,5-pyrazolidindione (DA 2370) in rheumatoid arthritis: clinical study with the use of a new weighted articular index].
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D011298:Feprazone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000031:analogs & derivatives*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011298:Feprazone; D010653:Phenylbutazone
Il 4-prenil-1,2-difenil-3,5-pirazolidindione (DA 2370) nell'artrite reumatoide: studio clinico con l'impiego di un nuovo indice articolare ponderato